174 results
8-K/A
EX-99.1
ATOS
Atossa Therapeutics Inc
1 Apr 24
Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update
7:18pm
in estimate of the amount that no longer met the reasonably assured threshold to be sustained under a potential ATO audit related to R&D expenditures under
8-K
EX-99.1
l7blqpqe705cq29s3xko
1 Apr 24
Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update
4:00pm
8-K
ngtoxn9e1ye
9 Nov 23
Departure of Directors or Certain Officers
9:00am
8-K
bc18iw
6 Oct 23
Departure of Directors or Certain Officers
4:00pm
8-K
ttrcbd8 rtsd26bm3
23 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:00am
8-K
1ii5ccjzam
22 May 23
Changes in Registrant's Certifying Accountant
4:12pm
8-K
EX-3.2
xohjd
26 Apr 23
Amendments to Articles of Incorporation or Bylaws
4:10pm